September 2005
"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 Please share these new ISPOR activities with your colleagues

  eBulletin Index

September 200

 

 ISPOR Bridging Health Care Research and Practice

 

NEW THIS MONTH

 

**NEW** ISPOR 2nd Asia-Pacific Conference – ABSTRACT DEADLINE 12 SEPTEMBER 2005

 **NEW** ISPOR Research Digest Now Includes 10th Annual International Meeting Contributed Research

**NEW** ISPOR Publication Discounts–NEW BOOKS

**NEW** Value In Health "On-Line Early" Manuscripts, Volume 8, Issue 5 & 6

**NEW** ISPOR Eighth Annual European Congress – UPDATES (OVER 700 CONTRIBUTED PRESENTATIONS!)

 **NEW** ISPOR Short Courses–ISPOR Eighth Annual European Congress & 11th Annual International Meeting – UPDATES

**NEW** ISPOR Special Interest Group (SIG) – UPDATES

**NEW** ISPOR Asia Consortium–UPDATES

 **NEW** 16 New Positions At The ISPOR Website

 **SPECIAL ANNOUNCEMENT** Course in Economic Evaluations in Healthcare at Bocconi University

 

    

 ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

9.       Asia Consortium and Local Chapter News

10.    Employment in Pharmacoeconomics and Outcomes Research

11.    Membership

 


  1. PUBLICATIONS

Top

 

VALUE IN HEALTH

 

Value in Health: Volume 8, Issue 4, July/August 2005 is online and available this month at: http://www.ispor.org/valueinhealth_index.asp.  The following is the TABLE OF CONTENTS for Value in Health Volume 8, Issue 4, July/August 2005:

 

POLICY AND APPLICATION

Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty-When Is There Sufficient Evidence?

Mark Sculpher, Karl Claxton

 

DECISION-MAKER COMMENTARY

An Aging Population-Burden or Blessing?

Alan Williams

 

Evidence-Based Practice to Evidence-Based Policy: Do We Really Impact on Patient Care?

Peter K. Wong

 

EMPIRICAL

Understanding Patient Preferences for HIV Medications Using Adaptive Conjoint Analysis: Feasibility Assessment

Kathleen M. Beusterien, Kristina Dziekan, Emuella Flood, Gale Harding, Jamie C. Jordan

 

Cost-Effectiveness Analysis of Rituximab Combined with CHOP for Treatment of Diffuse Large B-Cell Lymphoma

Jennie H. Best, John Hornberger, Stephen J. Proctor, Louis F. Omnes, Fred Jost

 

RELATIONSHIP BETWEEN INITIAL QUETIAPINE DOSE AND EFFECTIVENESS AS REFLECTED IN SUBSEQUENT MENTAL HEALTH SERVICE USE AMONG PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER

Frank Gianfrancesco, Ruey-hua Wang, Jacqueline Pesa

 

ELICITING WOMEN'S PREFERENCES FOR A TRAINING PROGRAM IN BREAST SELF-EXAMINATION: A CONJOINT RANKING EXPERIMENT

Mickael Bech, Jan Sorensen, Jorgen Lauridsen

 

COST SAVINGS FROM INTRAVENOUS IMMUNOGLOBULIN MANUFACTURED FROM CHROMOTOGRAPHY/CAPRYLATE (IGIV-C) IN PERSONS WITH PRIMARY HUMORAL IMMUNODEFICIENCY DISORDER

Parthiv J. Mahadevia, John Strell, Dan Kunaprayoon, Erwin Gelfand

 

PERSISTENCE AND ADHERENCE OF MEDICATIONS FOR CHRONIC OVERACTIVE BLADDER/URINARY INCONTINENCE IN THE CALIFORNIA MEDICAID PROGRAM

Yanni F. Yu, Michael B. Nichol, Andrew P. Yu, Jeonghoon Ahn

 

COST AND UTILIZATION IMPACTS OF ORAL ANTIHISTAMINES IN THE CALIFORNIA MEDI-CAL PROGRAM

Joel W. Hay, Michael Leahy

 

VALUE IN HEALTH "ON-LINE EARLY" MANUSCRIPTS

Volume 8, Issue 5, September/October 2005 "On-Line Early" will go on-line later this month. To view these "On-Line Early" articles, simply go to http://www.ispor.org/valueinhealth_index.asp, log on using your membership information, and follow the link.

 

ISPOR CONNECTIONS

   

ISPOR CONNECTIONS: Volume 11, Issue 4, July/August 2005 is now available to the public at: http://www.ispor.org/news/index_new.asp.

  

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS

  

"The ISPOR Book of Terms has been a real hit with our customers and employees alike.  It fills a gap for those who are new to Outcomes." Jenifer Ehreth, PhD, Director Reimbursement for Europe, Middle East and Africa Medtronic Europe

 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 100. 

 

**NEW**PUBLICATION DISCOUNTS–FOR ISPOR MEMBERS INCLUDES NEW BOOKS

     

ISPOR membership includes special discount prices on clinical, drug, pharmacoeconomics, health economic, quality of life, statistics, epidemiology, health-care purchasing, outcomes research and disease management reference books and journals. A select group of publications are offered to ISPOR members at discounted prices. 

 

New books included with ISPOR member discounts are:.

 

**USING COST-EFFECTIVENESS ANALYSIS TO IMPROVE HEALTH CARE (Oxford University Press) By Peter J. Neumann

ISPOR Members Cost: $28.00 (a 20% savings).

 

**METHODS FOR THE ECONOMIC EVALUATION OF HEALTH CARE PROGRAMS (Third Edition) (Oxford University Press)

By Michael Drummond

ISPOR Members Cost: $44.00 (a 20% savings).

 

**CHOICES, VALUES, AND FRAMES (Cambridge University Press)

Edited By Daniel Kahneman and Amos Tversy

ISPOR Members Cost: $39.19

 

**WELL-BEING: FOUNDATIONS OF HEDONIC PSYCHOLOGY (Russell Sage Foundation)

Edited by Daniel Kahneman, Ed Dinear, and Norbert Schwartz

ISPOR Members Cost: $28.00

 

**EVALUATING PHARMACEUTICALS FOR HEALTH POLICY AND REIMBURSEMENT (Blackwell Publishing)

By Nick Freemantle and Suzanne Hill

ISPOR Members Cost: $47.97 (a 40% savings)

 

To see all books & journals with ISPOR member disounts, go to:

 


  

  1. ISPOR MEETINGS AND CONGRESSES

Top

   

ISPOR EIGHTH ANNUAL EUROPEAN CONGRESS –OVER 850 ABSTRACTS SUBMITTED FOR THE ISPOR EIGHTH ANNUAL EUROPEAN CONGRESS - UPDATES

      6-8 November 2005 Palazzo Degli Affari, Florence , Italy

     "INCORPORATING VALUES INTO HEALTH CARE DECISIONS"

 

For more information on the ISPOR 8th Annual European Congress visit:

http://www.ispor.org/congresses/italy1105/index.asp

 

Posters & Podiums - *New ISPOR Record

Over 700 contributed presentations (64 podium presentations in 4 sessions and over 600 posters in 3 sessions)!  This is the highest number of abstract submissions and presentations in ISPOR's 10-year history.

 

Poster Session I: http://www.ispor.org/congresses/italy1105/posters1.asp

Poster Session II: http://www.ispor.org/congresses/italy1105/posters2.asp

Poster Session III: http://www.ispor.org/congresses/italy1105/posters3.asp

 

For poster and podium presentation information, visit: http://www.ispor.org/congresses/italy1105/presenters_index.asp

 

ISPOR Contributed Issue Panels:

Nine contributed Issue Panels on the following topics:

 

*Economic Outcomes Issues

*Clinical Outcomes Issues

*Quality of Life / Patient Reported Outcomes Issues

*Health Policy – Health Care Reimbursement Issues

*Risk Management Issues

 

ISPOR Contributed Workshops:

Thirty-two workshops on the following topics:

      

*Medication Compliance & Persistence

*Risk Management

*Population Health

*Managed Care Formulary Dossier Development or Research Agendas

*Patient Registries

*Health Technology Assessment

 

SPECIAL EVENT:

 

You Are Invited To Attend The

ISPOR 10th Anniversary Party 
Vincigliata Castle
Feisole, Italy

(TO BE HELD DURING THE ISPOR 8TH EUROPEAN CONGRESS)

MONDAY, 7 NOVEMBER 2005
20:00-23:30

WINE TASTING    DINNER BUFFET    MUSIC & DANCING

COMPLIMENTARY TRANSPORTATION

Buses will depart the Palazzo Delgi Affari at 20:15 and depart the Castle at 23:30. To register, go to: http://www.ispor.org/congresses/italy1105/10annivparty.asp

      Exhibitor Opportunities available at:

 

      Sponsorship Opportunities available at:

 

For more details about the Congress, go to: http://www.ispor.org/congresses/italy1105/index.asp

 

********************************************************************************

ISPOR 2nd ASIA-PACIFIC CONFERENCE - UPDATES

Shanghai Worldfield Convention Hotel, Shanghai, China • 5-7 March 2006

IMPROVING EVIDENCE AND OUTCOMES IN HEALTH CARE DECISION MAKING IN ASIA PACIFIC: CHALLENGE TO A NEW ERA

 

CO-ORGANIZED BY

ISPOR Asia Consortium

Fudan University, P.R. China

 

CO-SPONSORED BY:

Shanghai Municipal Government, P.R. China

Ministry of Labor and Social Security, P.R. China

Ministry of Health, P.R. China

State Food and Drug Administration, P.R. China

Shanghai City Food and Drug Administration, P.R. China

Peking University, P.R. China

The Chinese University of Hong Kong, P.R. China

Shanghai Academy of Social Sciences, P.R. China

Chinese Medical Association, P.R. China

Chinese Health Economics Association, P.R. China

Chinese Medical Doctor Association, P.R. China

China Licensed Pharmacist Association, P.R. China

Chinese Pharmaceutical Association, P.R. China

The Pharmaceutical Association of Thailand under the Royal Patronage, Thailand

China Social Insurance Association Medical Insurance Branch, P.R. China

Chinese Clinical Epidemiology Society, P.R. China

Chinese Cochrane Center, P.R. China

 

For updates, please visit: http://www.ispor.org/conferences/shanghai0306/sponsors.asp

 

ON-LINE ABSTRACT SUBMISSION DEADLINE: 12 SEPTEMBER 2005

Abstract submissions are invited for Contributed Research and Contributed Workshop. Abstracts submitted to the 10th or 11th Annual International Meeting or the 8th Annual European Congress can be submitted to this Conference. All abstracts should be submitted through http://ispor.confex.com/ispor/asia2/index.html.

 

SHORT COURSES:

Introduction to Pharmacoeconomics

Introduction to Quality of Life Assessment

Meta-Analysis and Systematic Literature Review

Introduction to Biostatistics in Clinical Trials

Introduction to Decision Analysis

Formulary Development

Budget Impact Analysis

Cost Analysis in Health Care

Retrospective Data Analysis

Modeling: Structure and Design of a Model

 

For further information, please visit: http://www.ispor.org/conferences/shanghai0306/p030505.asp

 

1st Plenary Session:

Pharmacoeconomics and Outcomes Research Development and Use in Asia

Moderator/Speaker:

Tony YH Tarn PhD, Director, Department of Pharmacy, Taipei City  

Hospital, Taipei, Taiwan

Speakers:

Shanlian Hu, MD, MSc, Professor, School of Public Health, Fudan University, Shanghai, China; Isao Kamae, MD, PH, Professor, Graduate School of Medicine, Kobe University, Kobe, Japan, Syed Mohamed Aljunid, MD, MSc, PhD, FAMM, Professor of Health Economics and Head of Department of Community Health, and Faculty of Medicine, Universiti Kebangsaan Malaysia; Shu-Chen Li, PhD, MS, MBA, Assistant Professor, Department of Pharmacy, National University of Singapore, Singapore, Bong-Min Yang, PhD, Professor of Economics and Dean, School of Public Health, Seoul National University, South Korea; and Viroj Tangcharoensathien, PhD, Director of International Health Policy Program Ministry of Public Health, Thailand.

 

2nd Plenary Session:

Development and Implementation of Pharmacoeconomics Requirements: International Experiences

Moderator/Speaker: Wen Chen, PhD, Professor and Associate Dean, School of Public Health, Fudan University

Speaker: Suzanne Hill, PhD, Associate Professor, Clinical Pharmacology
Faculty of Health University of Newcastle, Australia

 

8 PODIUM SESSIONS, 8 WORKSHOP SESSIONS and 9 CO-SPONSORED SPECIALSESSIONS:

For details, go to:

http://www.ispor.org/conferences/shanghai0306/p030605.asp http://www.ispor.org/conferences/shanghai0306/p030705.asp

 

FINANCIAL SUPPORT OPPORTUNITIES

Financial support opportunities are available at:

           

EXHIBITOR OPPORTUNITIES:

Exhibitor opportunities are available at:

 

EARLY REGISTRATIN DEADLINE: 5 FEBRUARY 2006

For further conference information, go to: http://www.ispor.org/conferences/shanghai0306/index.asp

 

********************************************************************************

**NEW** ISPOR Research Digest NOW INCLUDES 10th Annual International Meeting Contributed Research-UPDATE

 

The ISPOR RESEARCH DIGEST is an electronic database of over 5200 research papers presented at ISPOR Annual International Meetings, ISPOR Annual European Congresses, and ISPOR Asia-Pacific Conferences from 1998 to May 2005. This database can be searched by disease, topic, and meeting. To view the digest, go to: http://www.ispor.org/research_study_digest/index.asp.


 

  1. EDUCATION ACTIVITIES

Top

           

ISPOR SHORT COURSES–ISPOR 8TH ANNUAL EUROPEAN CONGRESS– UPDATES

 

Saturday, 6 November Short Courses:

 

Pharmacoeconomics for the Health Care Decision-Maker

Faculty: Ralph Crott PhD, MPH, Health Economist, Health Care Knowledge Center, Brussels, Belgium.

 

The Analysis and Interpretation of Quality of Life and Patient Reported Outcomes

Faculty: Linda Abetz MA, Director, Questionnaire Development and Validation, Mapi Values, Bollington, UK; Christine de la Loge Director, Psychometrics and Statistics Mapi Values, Lyon, France.

 

European Databases and Retrospective Database Analysis

Faculty: Bernd Brϋggenjϋrgen MD, MPH, Coordinator-Health Economics, University of Berlin, Berlin, Germany.

 

Cost Estimation and Assessing Financial (Budget) Impact of New Health Care Technologies  

Faculty: Josephine Mauskopf PhD, Global Head, Health Economics and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, USA; C. Daniel Mullins PhD, Professor and Chair of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, Baltimore, MD, USA.

 

Pharmacoeconomic Modeling
Faculty
: Uwe Siebert MD, MPH, MSc
, Decision Scientist, Director of the Cardiovascular Research Program, Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and Director of the Program on Health Technology Assessment and Decision Sciences (HTA&DS), Institute for Medical Informatics, Biostatistics, and Epidemiology, University of Munich, Munich, Germany; Gaby Sroczynski MPH, Decision Scientist, Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and Bavarian Public Health Research and Coordinating Center, University Munich, Germany.

 

For Saturday Short Courses descriptions, go to: http://www.ispor.org/congresses/italy1105/satsc.asp

 

Sunday, 6 November Short Courses:

 

Elements of Pharmaceutical Pricing

Faculty: Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ, USA; Renato Dellamano PhD, President, ValueVector (Value Added Business Strategies), Milan, Italy

 

Transferability of Cost-Effectiveness Data between Countries

Faculty: Michael Drummond PhD, Director, University of York, Centre for Health Economics, York, UK

 

Health Care and Reimbursement Systems in Europe 

Faculty: Gordon Carey Cambridge Pharma Consultancy Ltd., Cambridge, UK

 

Bayesian Methods in Economic Evaluations

Faculty: Anthony O'Hagan PhD, Professor of Statistics, University of Sheffield, Sheffield, South Yorkshire, UK; Jeremy E. Oakley PhD, Lecturer, Department of Probability and Statistics, University of Sheffield, Sheffield, UK; John Williams Stevens BSc, Statistician, AstraZeneca, Leicestershire, UK

 

Discrete Event Simulation for Economic Analysis

Faculty: J. Jaime Caro MDCM, FCRPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University, Montreal PQ and Scientific Director, Caro Research Institute, Concord, MA, USA; Jörgen Möller MSc Mech Eng, Simulation Specialist, Caro Research Institute, Concord, MA, USA

 

Utility Measurements (Preference-Based Techniques)

Faculty: Jan Busschbach PhD, Senior Investigator, Department for Medical Psychology and Psychotherapy and Erasmus Medical Center, Rotterdam, The Netherlands; Elly Stolk MSc, Institute for Medical Technology Assessment (iMTA), Erasmus University Medical Center Rotterdam, The Netherlands.

 

For Sunday Short Courses descriptions, go to: http://www.ispor.org/congresses/italy1105/sunsc.asp

 

**************************

 

ISPOR SHORT COURSES–ISPOR 11TH ANNUAL INTERNATIONAL MEETING – May 2006

 

Saturday, May 20, 2006

 

Pharmacoeconomics for Decision-makers

Faculty: Lorne Basskin PharmD, Clinical Coordinator, Pharmacy Services, North Shore Medical Center, Miami, FL, USA and President, Trinka Publications, Cooper City, FL, USA

 

Retrospective Database Analysis – Econometric Methods

Faculty: William H. Crown PhD, i3 Magnifi, Auburndale, MA, USA

 

Modeling: Design and Structure of a Model

Faculty: Marc Botteman MA, Managing Partner, PharMerit North America, Bethesda, MD , USA

 

Finding and Extracting Cost Data

Faculty: Judith A. O'Brien RN, BSPA, Vice President, Director of Cost Development Research, Caro Research Institute, Concord, MA, USA

 

Bayesian Analysis: Overview

Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA

 

Financial Impact / Cost of Illness

Faculty: Josephine Mauskopf PhD, Global Head, Health Economics and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, USA; C. Daniel Mullins PhD, Professor and Chair of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, Baltimore, MD, USA

 

Bayesian Analysis: Applications

Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA

 

Qualitative Methods for Quality of Life/Patient-reported Outcomes

Faculty: Judith Barr, Associate Professor and Director, Northeastern University, Boston, MA, USA

 

Sunday, May 21, 2006

 

Cost-Effectiveness Analysis alongside Clinical Trials

Faculty: TBD

 

Use of Real World Data in Outcomes Research

Faculty: TBD

 

Bayesian Analysis: Advanced

Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA

 

Discrete Event Simulation for Economic Analyses

Faculty: J.Jaime Caro MDCM, FCRPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University, Montreal PQ and Scientific Director, Caro Research Institute, Concord, MA, USA; Jörgen Möller MSc Mech Eng, Simulation Specialist, Caro Research Institute, Concord, MA, USA

 

Advanced Quantitative Methods for Quality of Life / Patient-Reported Outcomes

Faculty: John Ware PhD, CEO & Chief Science Officer, Quality Metric Incorporated, Lincoln, RI, USA

 

Elements of Pharmaceutical/Biotech Pricing I - Introduction

Faculty: Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ, USA;
Renato Dellamano PhD, President, ValueVector (Value Added Business Strategies), Milan, Italy

 

Statistical Considerations in Economic Evaluations

Faculty: Henry Glick PhD, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA; Jalpa Doshi PhD, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA;
Daniel Polsky PhD, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA

 

Propensity Scores and Comorbidity Risk Adjustment

Faculty: Fadia Shaya MPH, PhD, Assistant Professor/Associate Director, University of Maryland School of Pharmacy, Center on Drugs and Public Policy, Baltimore, MD, USA

 

Patient Registries: Overview & Application

Faculty: Jeff Trotter MBA, President, Ovation Research Group, Highland Park, IL, USA

 

Utility Measures in Health Economics and Outcomes Research

Faculty: F. Reed Johnson PhD, Senior Fellow, RTI Health Solutions, Research Triangle Park, NC, USA

 

Outcomes Research for Medical Devices & Diagnostics

Faculty: TBD

 

Case Studies in Pharmaceutical/Biotech Pricing II – Advanced

Faculty: Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ, USA; Renato Dellamano PhD, President, ValueVector (Value Added Business Strategies), Milan, Italy

 

Risk Assessment: Analysis and Management

Faculty: TBD

 

ISPOR DISTANCE LEARNING PROGRAM MODULES

ISPOR Distance Learning Program

  

The following module topics are currently available (over 40 modules):

·      Pharmacoeconomics

·      Pharmacoeconomic Evaluations & Methods

·      Cost-Effectiveness Analysis

·      Cost-Benefit Analysis

·      Cost-Utility Analysis

·      Patient-Reported Outcomes (Utilities, Health-Related Quality Of Life, Treatment  Satisfaction, Treatment Adherence, Patient Preferences)

·      Study Design in Pharmacoeconomics

·      Guidelines and Reference Standards

·      Pharmacoeconomics in Drug Development, Reimbursement and Marketing


 

  1. STUDENT NEWS

Top

 

START AN ISPOR STUDENT CHAPTER! Over 30 student chapters! For more information:

http://www.ispor.org/student/chapters_index.asp

 

POST YOUR RESUME ONLINE for employers to view for IPRAP – Internship – Professional Recruitment Center

 

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp        


  

  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

VALUE-BASED REIMBURSEMENT SIG

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/reimbursement.asp

 

HEALTH TECHNOLOGY ASSESSMENT SIG

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/hta.asp

 

TRANSLATING RESEARCH TO CLINICAL PRACTICE SIG

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/sigsindex.asp

 

PATIENT REGISTRY SIG

 

Member participation was recently solicited for this newly revived Special Interest Group.  The following are the Patient Registry SIG Working Group chairs:

 

·         Safety-Surveillance Working Group- Chair: Peter Malamis

·         Analytical Applications Working Group- Chair: Mohan Bala

·         Global Applications Working Group- Co-Chairs: Leanne Larson and Melva Covington

·         Technology Working Group- Chair: Hugh Levaux

 

Working Group Chairs are currently selecting Leadership Group members. Those who indicated their interest in participating in the groups above will be contacted and notified by the end of the month.

 

QUALITY OF LIFE SIG

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/qol.asp

 
MEDICATION COMPLIANCE & PERSISTENCE SIG

 

Issues & Methods Working Group

This working group is finalizing a manuscript, Medication Compliance and Persistence: Consensus on Terminology and Definitions for submission to Value in Health.  The following poster will be on display in Poster Session III at the8th European Congress:

 

PHP46: DEFINING COMPLIANCE/ADHERENCE AND PERSISTENCE: ISPOR SPECIAL INTEREST WORKING GROUP

Burrell A1, Wong P2, Ollendorf D3, Fuldeore M4, Roy A5, Fairchild C6, Cramer J7

1Sanofi-Aventis, Bridgewater, NJ, USA; 2 Good Samaritan Hospital, Dayton, OH, USA; 3 PharMetrics, Inc, Watertown, MA, USA; 4 Walgreens Health Services, Deerfield, IL, USA; 5 West Virginia University, Morgantown, WV, USA; 6 Alcon Laboratories, Fort Worth, TX, USA; 7 Yale University School of Medicine, West Haven, CT, USA

 

Economics of Medication Compliance Working Group

This working group is working on two manuscripts for submission to Value in Health incorporating compliance & persistence in Health Economics; and utilizing game theory, the human capital approach and bilateral bargaining.  A workshop will be presented at the 8th European Congress on Monday 7 November 2006, at 10.45-11.45: W10: Incorporating Measure of Compliance & Persistence In Pharmacoeconomic Evaluations.

 

Analyses Standards Working Group

The manuscript A Checklist for Medication Compliance Studies Using Retrospective Databases is being finalized, and the group is working on a checklist for prospective studies. A workshop will be presented at the 8th European Congress on Sunday 6 November 2006, at 15.30-16.30: W2: Methods for Medication Compliance Studies: Patient Compliance as a Predictor of Clinical and Economic Outcomes.

 

Education Working Group

A workshop will be presented at the 8th European Congress on Tuesday 8 November 2006, at 13.30-14.30: W18: Developing a Curriculum for Medication Compliance Using Curriculum mapping Strategy

 

For more details on the work of this SIG please visit http://www.ispor.org/sigs/medication.asp and attend the Forum to be held on Monday 7 November 17.00-18.00 at the ISPOR 8th European Congress, Florence, Italy.

   

RETROSPECTIVE DATABASE SIG

 

Classification of Databases Working Group – ISPOR DIGEST OF INTERNATIONAL DATABASES

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is developing an electronic index (Digest) of key attributes of health care databases around the world at the ISPOR website, which will be accessible to the public. This Digest is an initiative of the ISPOR Retrospective Database Special Interest Group. For more information about this ISPOR Special Interest Group, see: http://www.ispor.org/sigs/retrospective_db.asp.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/retrospective_db.asp

 

RISK MANAGEMENT SIG

 

The Risk Management Special Interest Group (RMSIG) Working Groups are:

 

  • Risk/Benefit Assessment Working Group–Co-Chairs: Larry Liu MD, PhD, Director, Anti-Infectives US Outcomes Research, Pfizer, New York, NY, USA; and Suellen Curkendall PhD, Principal Investigator, Cerner Health Insights, Vienna, VA, USA.
  • Risk/Benefit Interventions Working Group–Chair: Anthony Lockett MBA, MD, PhD, Medical Director OHI, Leeds, W. Yorkshire, UK
  • Risk/Benefit Management Best Practices Working Group–Chair: TBD
  • Risk/Benefit Communication Working Group–Chair: Ateequr Rahman MBA, PhD, Assistant Professor, College of Pharmacy, Shenandoah University, Winchester, Virginia, USA
  • Risk/Benefit Legal/Regulation Working Group–Chair: TBD

 

For an overview of this RMSIG initiative, see the article “ISPOR Risk Management Special Interest Group–A Plan for Action,” in ISPOR CONNECTIONS, September/October 2005 issue.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/rm.asp and join as a reference or leadership group member.

 

Special Interest Group membership is open to ALL ISPOR members. To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 


 

  1. ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top

       

AWARD COMMITTEE ACTIVITIES

 

ISPOR AVEDIS DONABEDIAN OUTCOMES RESEARCH LIFETIME ACHIEVEMENT AWARD

 

The ISPOR Awards Committee is seeking nominees for the ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award.

 

See http://www.ispor.org/awards/donabedian_.asp

For award description, criteria, selection process, nature of the award, and past recipients.

 

The deadline to submit nominees is DECEMBER 15, 2005.

 

ISPOR TASK FORCE: USING "REAL WORLD" DATA IN COVERAGE AND REIMBURSEMENT DECISIONS

  

A draft of the final paper is currently circulating amongst Working Group Members.  After edits made by these core group members, a second draft will then be sent to the Review Team of the Using ‘Real World’ Data Task Force.

 

The task force will also be sharing their work during the Using ‘Real World’ Data Task Force Forum on Monday, November 7th at 5:00pm during the ISPOR 8th Annual European Congress, Florence, Italy.

 

ISPOR TASK FORCE: BUDGET IMPACT ANALYSIS

 

The Budget Impact Analysis Task Force was created in May 2005 to establish good research practice methods for conducting and reviewing budget impact analyses.  The report of this Task Force will be published in ISPOR Value in Health and at the ISPOR website in 2006.

 

The Task Force is presenting a workshop summary of their report at the upcoming ISPOR 8th Annual European Congress in Florence, Italy, November 2005.  The workshop will take place Monday, November 5 at 5:00 PM and will feature the following speakers:

 

Task Force Co-Chairs: Josephine Mauskopf PhD, VP, Health Economics, RTI Health Solutions, RTI International, Research Triangle Park, NC, USA; Sean Sullivan MS, PhD, RPh, Professor and Director, University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA

 

Lieven Annemans MSc, PhD, Health Economist Ghent University, Senior Consultant Global Health Economics, HEDM and IMS Health, Brussels, Belgium; J. Jaime Caro MD, Scientific Director, Caro Research, Concord, MA, USA; C. Daniel Mullins PhD, Professor and Chair, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA; Mark Nuijten MBA, MD, PhD, Sr. Research Scientist, Dir. of Business Dev., MEDTAP International, Inc., Jisp, The Netherlands; Ewa Orlewska PhD, Lecturer, Pharmacoeconomics Centre Warsaw, Warsaw; Paul Trueman MA, Sales & Marketing Director, York Health Economics Consortium, University of York, York, UK; John Watkins MPH, RPh, Pharmacy Manager, Formulary Development, Premera Blue Cross, Bothell, WA, USA; Andrew Wilson BMedSc, MB SC, FRACP, MSc, Deputy Director and Professor of Public Health, University of Queensland, School of Public Health, Brisbane, Australia

 

For more, please visit the ISPOR website at: http://www.ispor.org/workpaper/practices_index.asp.

  1. HOT TOPICS

Top

 

MEDICARE DRUG PLANS OFFER PREMIUMS OF $20 PER MONTH OR LESS LOWER DEDUCTIBLES, ENHANCED COVERAGE ALSO AVAILABLE

 

August 29, 2005 – Medicare beneficiaries all over the country will be able to choose prescription drug coverage that will cost less than originally expected, including plans with premiums of $20 per month or less. Options will also include plans offering zero deductibles or deductibles lower than $250 annually, and plans that provide some coverage in addition to the "standard" Medicare drug benefit.

 

For full text of the article, see: http://www.hhs.gov/news/press/2005pres/20050829.html


 

  1. IMPORTANT DATES TO REMEMBER

Top

  

12 September 2005 - On-line abstract submission deadline for ISPOR 2nd Asia-Pacific Conference, Shanghai Worldfield Convention Hotel, Shanghai, China

 

4 October 2005 - Early registration deadline for ISPOR 8th European Congress, Palazzo Degli Affari, Florence, Italy

 

8-11 November 2005 – ISPOR 8th European Congress, Palazzo Degli Affari, Florence, Italy

 

9 January 2006 – On-line abstract submission deadline for ISPOR 11th Annual International Meeting, Marriot Philadelphia, Philadelphia , PA

 

5-7 March 2006 – ISPOR 2nd Asia-Pacific Conference, Shanghai Worldfield Convention Hotel, Shanghai, China

 

20-26 May 2006 – ISPOR 11th Annual International Meeting, Marriott Philadelphia, Philadelphia, PA


 

  1. ASIA CONSORTIUM AND LOCAL CHAPTER NEWS

Top

 

**NEW**ISPOR ASIA CONSORTIUM–UPDATES

 

Dr Syed Mohamed Aljunid, MD, MSc, PhD, FAMM, Professor of Health Economics and Head of Department of Community Health and Faculty of Medicine, University Kebangsaan Malaysia, Malaysia and Dr Urmila Mukund Thatte, PhD, DNB, MD, MBBS, Professor and Head, Department of Clinical Pharmacology, Topiwala National Medical College and BYL Nair Charitable Hospital Mumbai Central, India joined ISPOR Asia Consortium Executive Committee. Thus, ISPOR Asia Consortium extends its presentation to China, Japan, India, Malaysia, Singapore, South Korea, Taiwan, and Thailand.

 

For more details on this consortium, please visit: http://www.ispor.org/consortiums/asia.asp

 

ISPOR Japan Chapter inaugurated on 1 September, 2005.

For more details on this chapter, please visit: http://www.ispor.org/regional_chapters/Japan/index.asp

 

ISPOR 2ND ASIA-PACIFIC CONFERENCE

The ISPOR 2nd Asia-Pacific Conference will be held in Shanghai, China, 5-7 March 2006. Abstract submission begins 1 July 2005 and ends 3 October 2005.  Early registration deadline is 5 February 2006.

 

For more details on the 2nd Asia-Pacific Conference, please visit: http://www.ispor.org/conferences/shanghai0306/index.asp

 

For more details on other ISPOR Local Chapters, please visit: Regional Chapters

 


  1. EMPLOYMENT

Top

**NEW** 16 NEW POSITIONS AT THE ISPOR WEBSITE: Careers

 

Advertise your positions on ISPOR Website (~1 million hits per month)

 

INTERNSHIPS

Visit ISPOR's Internship-Professional Recruitment Assistance Program (I-PRAP) at

 

STUDENTS: Post your CVs/resumes for employers to view and search for internship positions available.  Nine student resumes posted! 

 

EMPLOYERS: Post your Intern positions for FREE and access CVs/resumes from students.

 

If you have any questions, please contact: iprap@ispor.org.


 

  1. ISPOR MEMBERSHIP

Top

 

Update your email address at https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log in information in the members only section of the ISPOR website. 

  

 **SPECIAL ANNOUCMEMENT** Course in Economic Evaluations in Health Care at Bocconi University

 

Bocconi University School of Management:

Public Administration, Health Care and Not for Profit Division

 

Executive Course in

ECONOMIC EVALUATIONS IN HEALTH CARE: Bridging The Gap Between Science And Policy Making

 

Milan (Italy) - October 25-28, 2005 

In many countries government institutions recognize the role of economic evaluation in decision making and endorse guidelines on how to perform appropriate studies. Although recently there have been some improvements, the gap between science and policy making still exists. The objective of this 4-day course is to promote understanding and exchange experience among principal actors involved in bridging the gap: industry, academia and decision makers.

 

The course offers in-depth discussion of official requirements across Europe and analyses the perspective of decision makers in different countries through case-studies, discussion and the contribution of guest speakers coming from prominent international organizations (NICE,WHO).

 

It is designed for professionals who wish to acquire an up-to-date knowledge of current issues in economic evaluation analysis and its impact on decision makers: Regulatory Affairs Directors/Managers, Pricing and Reimbursement Directors/Managers, Marketing Directors, Medical Directors, Product Managers and all other personnel involved in initiating, undertaking, managing or interpreting economic evaluation analysis in pharmaceutical and medical device companies.

 

For further information, please visit: http://www.sdabocconi.it/dap/71883.

 

 


eBulletin Index